prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Research Gross Description. Research Dx. Left breast (1945 g), mastectomy: Invasive lobular carcinoma. 7 regional lymph nodes, negative for malignancy (0/7). Tumor site: Upper outer quadrant ( 2-3:00). Tumor size: Between 7 and 9 cm. Histopathologic type: Invasive lobular carcinoma. Histopathologic grade (Nottingham): 2. Mitotic count: Low proliferative rate. Pathologic tumor stage: pT3. Margin status: Distance of carcinoma from margins: Superior: 0.8 cm. Inferior: At least 1 cm. Medial: Greater than 2 cm. Lateral: Greater than 2 cm. Anterior: 1 cm. Posterior: Greater than 1 cm. Associated in situ carcinoma: Type: Lobular carcinoma in situ (rare focus). Extensive (>25% of total tumor): No. Separate (extra-tumoral) foci away from main lesion: Not identified. Peritumoral angiolymphatic invasion: Not identified. Dermal angiolymphatic invasion: Not identified. Estrogen receptor: Positive (70 % of tumor cell nuclei staining moderately to strongly). Progesterone receptor: Positive (70 % of tumor cell nuclei staining moderately to strongly). HER-2/neu (ERBB2): Negative (score 0). Duration of fixation in 10% NBF: 12 hours 24 minutes. Appropriate internal and external controls: Yes. Standard assay conditions met? Yes. Pathologic lymph node stage: pNO (including sentinel): No regional lymph node metastasis. Number of nodes positive for metastasis/total number nodes sampled: 0/11. Maximum diameter of largest lymph node metastasis: Not applicable. Extranodal extension by tumor: Not applicable. Distant metastasis: M-not applicable. Additional pathologic findings: Fibrocystic change and usual ductal hyperplasia; seborrheic. keratosis. TNM descriptors (if applicable): AJCC Staging (7th Edition): pT3 pNO M-not applicable. Research QC. T1 Tumor: 50% tumor nuclei. 0% necrosis. 50% normal. Normal: 100% fibroadipose. 1. T2. 50% tumor nuclei. 0% necrosis. 50% normal fibrous tissue and fat. minimal normal breast. T3. 70% tumor nuclei. 0% necrosis. 30% normal. T4. 50% tumor nuclei. 0% necrosis. 50% normal fat, could prob be trimmed. Research Specimen. Specimen Process Time. Blood draw time. Plasma frozen time: Serum frozen time. Buffy coat frozen time: Cold ischemia start time: Formalin fixation start time: Total cold ischemia time: Formalin fixation stopped time. Total formalin fixation time: Specimen Weight. Cryovials x 8. Normal X 4 - 1.) 335 mg 2.) 321 mg 3.) 408 mg 4.) 447 mg. Tumor x 4 - 1.) 351 mg 2.) 357 mg 3.) 252 mg 4.) 322 mg. Specimen Size. Plasma x 3. Serum x 2. Buffy coat X 1. Cryovials X 8. Normal x 4. Tumor X 4. FFPE x 8. Normal x 4. Tumor x 4. Study. Patient Consent. 2.

expanded version (tokens=1156) : 
 The breast pathology report reveals the following information:

1. Histological classification: Invasive lobular carcinoma with a subtype of LumA.

2. Tumor size and stage: The tumor is between 7 and 9 cm and is classified as pT3.

3. Histopathologic grade and mitotic count: The histopathologic grade (Nottingham) is 2, with a low proliferative rate.

4. Lymph node involvement: No regional lymph node metastasis found, with 7 negative lymph nodes tested.

5. Margin status: Clear margins from carcinoma with a distance of superior 0.8cm, inferior at least 1cm, medial greater than 2cm, lateral greater than 2cm, anterior 1cm, and posterior greater than 1cm.

6. Associated in situ carcinoma: Lobular carcinoma in situ (rare focus) was identified.

7. Estrogen receptor (ER) and progesterone receptor (PR) status: ER and PR positive with 70% of tumor cell nuclei staining moderately to strongly.

8. HER-2/neu status: Negative (score 0).

9. Receptor status: LumA subtype.

10. Necrosis: There is no mention of necrosis observed.

11. Tumor infiltrating lymphocytes: Not identified.

12. Lymphovascular invasion: Neither peritumoral nor dermal angiolymphatic invasion were identified.

13. Ancillary testing results: No extr

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1311) : 
 The report shows a LumA subtype invasive lobular carcinoma, with a size between 7 and 9 cm and classified as pT3. There is no lymph node involvement or angiolymphatic invasion discovered. Clear margins were observed with a rare focus of lobular carcinoma in situ, ER and PR are positive with 70% moderately to strong staining of tumor cell nuclei. HER-2/neu test returned negative (score 0). No necrosis or information on tumor-infiltrating lymphocytes were mentioned in the report.

